Identification of a characteristic VOCs pattern in the exhaled breath of post-COVID subjects: are metabolic alterations induced by the infection still detectable?

SARS-CoV-2 is expected to cause metabolic alterations due to viral replication and the host immune response resulting in increase of cytokine secretion and cytolytic activity. The present prospective observational study is addressed at exploring the potentialities of breath analysis in discrimination between patients with a documented previous history of symptomatic SARS-CoV-2 infection and, at the moment of the enrollment, exhibiting a negative nasopharyngeal swab and acquired immunity (post-COVID) and healthy subjects with no evidence of previous SARS-CoV-2 infection (no-COVID). The main purpose is to understand if traces of metabolic alterations induced during the acute phase of the infection are still detectable after negativization, in the form of a characteristic volatile organic compound (VOC) pattern. An overall number of 60 volunteers aged between 25 and 70 years were enrolled in the study (post-COVID: n.30; no-COVID: n. 30), according to well-determined criteria. Breath and ambient air samples were collected by means of an automated sampling system (Mistral) and analyzed by thermal desorption-gas chromatography-mass spectrometry (TD-GC/MS). Statistical tests (Wilcoxon/Kruskal–Wallis test) and multivariate data analysis (principal component analysis (PCA), linear discriminant analysis) were performed on data sets. Among all compounds detected (76 VOCs in 90% of breath samples), 5 VOCs (1-propanol, isopropanol, 2-(2-butoxyethoxy)ethanol, propanal and 4-(1,1-dimethylpropyl)phenol) showed abundances in breath samples collected from post-COVID subjects significantly different with respect to those collected from no-COVID group (Wilcoxon/Kruskal–Wallis test, p-values <0.05). Although not completely satisfactory separation between the groups was obtained, variables showing significant differences between the two groups and higher loadings for PCA are recognized biomarkers of COVID-19, according to previous studies in literature. Therefore, based on the outcomes obtained, traces of metabolic alterations induced by SARS-CoV-2 infection are still detectable after negativization. This evidence raises questions about the eligibility of post-COVID subjects in observational studies addressed at the detection of COVID-19. (Ethical Committee Registration number: 120/AG/11).

[1]  Y. Shoenfeld,et al.  Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form , 2021, Pathogens.

[2]  M. McCartney,et al.  Predominant SARS-CoV-2 variant impacts accuracy when screening for infection using exhaled breath vapor , 2022, Communications medicine.

[3]  Han Jin,et al.  Intelligent COVID-19 screening platform based on breath analysis , 2022, Journal of breath research.

[4]  Amanda P. Siegel,et al.  Exhaled VOCs can discriminate subjects with COVID-19 from healthy controls , 2022, Journal of breath research.

[5]  D. Adam The pandemic’s true death toll: millions more than official counts , 2022, Nature.

[6]  A. Berna,et al.  Breath Metabolites to Diagnose Infection , 2021, Clinical chemistry.

[7]  M. Yao,et al.  COVID-19 screening using breath-borne volatile organic compounds , 2021, Journal of breath research.

[8]  Lowilius Wiyono,et al.  The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis. , 2021, Diagnostic Microbiology and Infectious Disease.

[9]  B. Hargadon,et al.  Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography–mass spectrometry , 2021, ERJ Open Research.

[10]  A. Berna,et al.  Reproducible breath metabolite changes in children with SARS-CoV-2 infection , 2020, medRxiv.

[11]  D. Annane,et al.  Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study , 2020, EBioMedicine.

[12]  P. Barbieri,et al.  Breath Analysis: Comparison among Methodological Approaches for Breath Sampling , 2020, Molecules.

[13]  S. Engelen,et al.  Applying the electronic nose for pre-operative SARS-CoV-2 screening , 2020, Surgical Endoscopy.

[14]  P. Trerotoli,et al.  Chemical signature of colorectal cancer: case–control study for profiling the breath print , 2020, BJS open.

[15]  Yong Wang,et al.  Multiplexed Nanomaterial-Based Sensor Array for Detection of COVID-19 in Exhaled Breath , 2020, ACS nano.

[16]  M. Reed,et al.  Diagnosis of COVID-19 by analysis of breath with gas chromatography-ion mobility spectrometry - a feasibility study , 2020, EClinicalMedicine.

[17]  M. F. Bashir,et al.  A brief review of socio-economic and environmental impact of Covid-19 , 2020, Air Quality, Atmosphere & Health.

[18]  J. V. van Meerbeeck,et al.  The scent of COVID-19: viral (semi-)volatiles as fast diagnostic biomarkers? , 2020, Journal of breath research.

[19]  Weihua Yang,et al.  Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection kits and strategy to reduce false negative , 2020, medRxiv.

[20]  R. Bellotti,et al.  Breath Analysis for Early Detection of Malignant Pleural Mesothelioma: Volatile Organic Compounds (VOCs) Determination and Possible Biochemical Pathways , 2020, Cancers.

[21]  M. Abu-Farha,et al.  The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target , 2020, International journal of molecular sciences.

[22]  Stefan R. Bornstein,et al.  The ACE-2 in COVID-19: Foe or Friend? , 2020, Hormone and Metabolic Research.

[23]  M. Cazzola,et al.  Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? , 2020, Respiratory Medicine.

[24]  Zebao He,et al.  Proteomic and Metabolomic Characterization of COVID-19 Patient Sera , 2020, Cell.

[25]  N. Ratcliffe,et al.  A mechanistic study and review of volatile products from peroxidation of unsaturated fatty acids: an aid to understanding the origins of volatile organic compounds from the human body , 2020, Journal of breath research.

[26]  E. Ifeachor,et al.  Breath-based non-invasive diagnosis of Alzheimer’s disease: a pilot study , 2019, Journal of breath research.

[27]  K. Van Steen,et al.  Exhaled Volatile Organic Compounds are Able to Discriminate between Neutrophilic and Eosinophilic Asthma. , 2019, American journal of respiratory and critical care medicine.

[28]  D. Galetta,et al.  Breath Analysis: A Systematic Review of Volatile Organic Compounds (VOCs) in Diagnostic and Therapeutic Management of Pleural Mesothelioma , 2019, Cancers.

[29]  Pierre‐Hugues Stefanuto,et al.  Exhaled Volatile Organic Compounds Are Able to Discriminate Between Neutrophilic and Eosinophilic Asthma , 2019, A93. ASTHMA BREAKTHROUGHS: THE ROLE OF THE IMMUNE SYSTEM IN HUMAN ASTHMA.

[30]  W. Miekisch,et al.  VOC breath profile in spontaneously breathing awake swine during Influenza A infection , 2018, Scientific Reports.

[31]  L. Bos,et al.  Exhaled breath metabolomics for the diagnosis of pneumonia in intubated and mechanically ventilated ICU–patients , 2017 .

[32]  F. Porcelli,et al.  The use of the PEN3 e-nose in the screening of colorectal cancer and polyps , 2016, Techniques in Coloproctology.

[33]  M. Schivo,et al.  Volatile emanations from in vitro airway cells infected with human rhinovirus , 2014, Journal of breath research.

[34]  M. Schivo,et al.  Cellular Scent of Influenza Virus Infection. , 2014, Chembiochem : a European journal of chemical biology.

[35]  Gert Mayer,et al.  Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease , 2014, BMC Nephrology.

[36]  B. Buszewski,et al.  The application of statistical methods using VOCs to identify patients with lung cancer , 2011, Journal of breath research.

[37]  L. Trizio,et al.  Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure , 2010, Analytical and bioanalytical chemistry.

[38]  Magdalena Ligor,et al.  Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry , 2009, Clinical chemistry and laboratory medicine.

[39]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.